LIVECAST Markets Briefs Calendar

Research

News Search AI Market Assistant Charts & News Instrument directory Macro Politics News Archive

LIVECAST Markets

☀◐Theme

Menu

Home LIVECAST Markets Briefs Calendar News Search AI Market Assistant Charts & News Instrument directory Macro Politics News Archive Account

Home News ArchiveFTC subpoenas OpenAI, Anthropic over potential consumer protection violations: Axios

Live News REGULATION FLASH L impact Oct 15, 2026, 09:23 AM UTC

FTC subpoenas OpenAI, Anthropic over potential consumer protection violations: Axios

SquawkNews Desk

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

No ticker tags on this item.

Related stories

SLS Bio Seeks Injunction to Suspend Delisting Decision SLS Bio applied to the Seoul Southern District Court on October 26, 2026, for an injunction suspending the delisting decision and related measures against the Korea Exchange. L impact | REGULATION | Oct 26, 2026, 08:53 AM UTC DFSA Restricts Peters From Financial Services Functions in DIFC The DFSA restricted Peters from performing any function connected with providing financial services in or from the DIFC. L impact | REGULATION | Oct 26, 2026, 08:48 AM UTC DFSA Bars Peters From Office at Authorized Firms or Funds The DFSA prohibited Peters from holding office or working for a DFSA-authorized firm or fund, in addition to a fine. L impact | REGULATION | Oct 26, 2026, 08:47 AM UTC DFSA Fines Gary Joseph Peters $210,000 The DFSA fined Gary Joseph Peters $210,000 for misleading the regulator and failing to produce documents. L impact | REGULATION | Oct 26, 2026, 08:46 AM UTC South Korean President Says CPTPP Deal May Not Be Reached During Term South Korean President Lee said a CPTPP deal may not be reached during his term. L impact | REGULATION | Oct 26, 2026, 08:45 AM UTC Bayer Wins First Global Approval for Stroke Prevention Drug in China Bayer said China authorized the launch of its drug to prevent recurrent stroke, marking the first global approval for a new class of medicines. M impact | REGULATION | Oct 26, 2026, 08:43 AM UTC

SQUAWK/NEWS

Independent financial newsroom. Editorial expertise and proprietary AI. Paid LiveCast brings live headlines, chart context and priority audio to your trading day. Free research tools remain available.

LiveCast passes from $15 · Institutional API access.

Start LiveCast

News & Research

Open LiveCast
Session Briefs
Macro
Politics
News Archive

Markets & Tools

Charts & News
Markets Overview
US Stocks
Market Movers
Economic Calendar
Policy Calendar
AI Market Assistant
News Search
Instrument Directory

Guides

Charts & News Guide
How LiveCast Works
What Is an Audio Squawk?
Why News Moves Markets
News for Traders
How to Trade the News

Plans & API

Plans & Pricing
Institutional API
RSS Feed

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact us

© 2026 SquawkNews

Privacy Policy Terms of Use

SquawkNews publishes market information and context. It does not provide investment advice or trade recommendations.